Are Syncom Formul. latest results good or bad?

Jun 07 2025 03:58 AM IST
share
Share Via
Syncom Formulations (India) reported strong financial results for Q1 2025, with a Profit After Tax of Rs 17.68 crore and record net sales of Rs 148.88 crore, marking significant growth compared to previous quarters. However, the reliance on non-operating income raises concerns about sustainability.
Syncom Formulations (India) has reported notable financial results for the quarter ending March 2025. The company declared a Profit After Tax (PAT) of Rs 17.68 crore, which reflects a substantial growth compared to the average PAT of Rs 9.79 crore over the previous four quarters, marking the highest PAT recorded in the last five quarters.

Net sales reached a record high of Rs 148.88 crore, demonstrating growth from the previous four-quarter average of Rs 97.68 crore. The operating profit (PBDIT) was reported at Rs 17.76 crore, indicating a consistent upward trend over the last five quarters. Profit Before Tax (PBT) also showed growth, reported at Rs 16.35 crore, up from the average of Rs 9.66 crore in the previous four quarters. Additionally, the Earnings per Share (EPS) reached Rs 0.19, the highest in the last five quarters, highlighting enhanced profitability.

However, it is important to note that the company reported a non-operating income of Rs 6.94 crore, which may not be sustainable in the long term.

In terms of quarterly performance, the net sales growth for the quarter ended March 2025 was recorded at 16.74%, compared to 24.65% in the previous quarter. The consolidated net profit growth for the same period was 36.08%, an increase from 17.01% in the prior quarter. The operating profit margin (excluding other income) was reported at 11.93%, with a slight change from the previous quarter's margin of 11.55%.

Overall, Syncom Formulations (India) has seen an adjustment in its evaluation, reflecting the operational trends and financial performance reported.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Syncom Formul. falling/rising?
Nov 25 2025 01:16 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 17 2025 08:10 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 16 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 15 2025 08:10 AM IST
share
Share Via